Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
基本信息
- 批准号:7939604
- 负责人:
- 金额:$ 13.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The objective of this new proposal is to use an interactive, collaborative, multidisciplinary approach to train talented young physician-scientists (MD and MD PhD) or PhD scientists for a successful career in investigative hematology research. The rationale for developing this program is our belief that Mount Sinai School of Medicine offers diverse scientific opportunities in an outstanding research environment, that we have a faculty that is dedicated to training scientists and physician-scientists for a career in academic hematology, stem cell biology, and regenerative medicine, and that we wish to have an impact on the education of future investigative hematologists. Faculty has been integrated into this program from various departments and institutes and from the Rockefeller University. Candidates for this training grant will be expected to devote a minimum of two years to training in basic or translational hematology. The trainees will select a mentor from one of the eight broad areas encompassed by this program: normal and malignant hematopoiesis, developmental hematopoiesis, adult and embryonic stem cell research, analysis of signaling pathways in hematologic processes, cell adhesion and migration within hematopoietic tissues and the vasculature, normal coagulation and inherited clotting disorders, immune cell development and function, and cell and gene therapy and transplantation. Throughout the training period, trainees will devote at least 90% of their time to research. Trainees will focus on an individualized research project under the guidance of one or more faculty preceptors. In addition, they will participate in weekly laboratory meetings, spend a portion of their time attending specific divisional, departmental and institutional research-oriented conferences, and will enroll in didactic, graduate level courses during the first and second years of training. Along with the enormous growth in the research portfolio of the Division of Hematology and Medical Oncology and the recruitment of new faculty over the past decade, we are now in a very strong position to provide an exceptional training opportunity that should be a magnet for the many outstanding trainees who wish to pursue a career in academic hematology research in New York City.
描述(由申请人提供):
这项新提案的目的是使用一种互动,协作,多学科的方法来培训有才华的年轻医师科学家(MD和MD博士学位)或博士学位科学家,以成功地从事调查血液学研究。制定该计划的理由是我们相信西奈山医学院在杰出的研究环境中提供了多样的科学机会,我们有一个专门用于培训科学家和医师科学家,从事学术血液学,干细胞生物学和再生医学的职业,并且我们希望对未来研究研究血液学的教育产生影响。教职员工已从各个部门和学院以及洛克菲勒大学纳入该计划。预计该培训赠款的候选人将至少两年用于基本或转化血液学培训。 The trainees will select a mentor from one of the eight broad areas encompassed by this program: normal and malignant hematopoiesis, developmental hematopoiesis, adult and embryonic stem cell research, analysis of signaling pathways in hematologic processes, cell adhesion and migration within hematopoietic tissues and the vasculature, normal coagulation and inherited clotting disorders, immune cell development and function, and cell and gene therapy和移植。在整个培训期间,学员将至少将90%的时间用于研究。在一个或多个教职员工的指导下,学员将专注于个性化的研究项目。此外,他们将参加每周的实验室会议,花费一部分时间参加特定的部门,部门和机构研究的会议,并在培训的第一年和第二年参加教学课程,研究生级课程。在过去十年中,血液学和医学肿瘤科研究组合的巨大增长以及新教师的招募外,我们现在处于非常强大的地位,可以为许多希望从事纽约市学术血液学研究的杰出培训者提供出色的培训机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret H Baron其他文献
Margaret H Baron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret H Baron', 18)}}的其他基金
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
核受体转录因子 VDR 对红细胞祖细胞的调节
- 批准号:
10392918 - 财政年份:2015
- 资助金额:
$ 13.37万 - 项目类别:
Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
VDR 核受体转录因子对红细胞生成的调节
- 批准号:
9260873 - 财政年份:2015
- 资助金额:
$ 13.37万 - 项目类别:
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
核受体转录因子 VDR 对红细胞祖细胞的调节
- 批准号:
9976495 - 财政年份:2015
- 资助金额:
$ 13.37万 - 项目类别:
Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
VDR 核受体转录因子对红细胞生成的调节
- 批准号:
9052176 - 财政年份:2015
- 资助金额:
$ 13.37万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
7762477 - 财政年份:2009
- 资助金额:
$ 13.37万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8128585 - 财政年份:2009
- 资助金额:
$ 13.37万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8496860 - 财政年份:2009
- 资助金额:
$ 13.37万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8320212 - 财政年份:2009
- 资助金额:
$ 13.37万 - 项目类别:
相似国自然基金
DMWD结合LATS1通过负向调控Hippo-YAP信号通路促进恶性胶质瘤干性的分子机制
- 批准号:82302980
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
- 批准号:32370337
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
转移相关中性粒细胞(TMAN)代谢重塑促三阴性乳腺癌嗜肺转移的作用与分子机制
- 批准号:82372823
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高温胁迫交叉锻炼对梭梭幼苗耐旱性影响的分子机理研究
- 批准号:32360079
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
AeAPX1交叉调控毛花猕猴桃果实AsA代谢与耐热性的分子机制
- 批准号:32302490
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the role of DCAF7 on hematopoietic stem cell maintenance
阐明 DCAF7 对造血干细胞维持的作用
- 批准号:
10785443 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别:
Understand Non-canonical RAS Signaling in Clonal Hematopoietic Disorders
了解克隆性造血疾病中的非典型 RAS 信号转导
- 批准号:
10571352 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别:
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantation
干细胞移植后骨髓增生异常综合征线粒体遗传的预后意义
- 批准号:
10662946 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别:
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients
炎症性肠病患者预防静脉血栓栓塞的抗凝剂使用、安全性和有效性
- 批准号:
10887842 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别: